Stephen Feider, Chief Financial Officer at Beta Bionics, Inc. (BBNX), sold 9,900 shares at $21.13 ($209K) on 2025-09-08, disclosed to the SEC on 2025-09-09.
Scheduled sale ($209k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BBNX | SELL | 2026-06-03 | $84K | — | Filing → |
| BBNX | SELL | 2026-03-03 | $18K | — | Filing → |
| BBNX | SELL | 2026-01-05 | $591K | — | Filing → |